Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation

An oral combination therapy of two antiretroviral drugs, the non-nucleoside rilpivirine (Edurant, also in Eviplera/Complera) and the new integrase inhibitor GSK1265744 (744), was at least as effective as

Published
08 March 2014
By
Gus Cairns
Protected T-cells persist and proliferate in HIV gene therapy study

Genetically modified CD4 T-cells lacking CCR5 co-receptors reach high levels in the body and are resistant to HIV infection, potentially enabling people to maintain a low viral

Published
07 March 2014
By
Liz Highleyman
Raltegravir has the edge over two protease inhibitors in three-drug comparison study

In a head-to-head comparison of three drugs presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI) on Wednesday, the integrase inhibitor raltegravir (Isentress) proved to

Published
07 March 2014
By
Gus Cairns
The 'Boston patients' experience HIV rebound after stem cell transplants

HIV has re-emerged in two Boston men who underwent experimental antiretroviral therapy interruption after receiving bone marrow stem cell transplants for cancer treatment, Timothy Henrich reported yesterday at the

Published
07 March 2014
By
Liz Highleyman
Two new studies point to impact of HIV treatment on transmission in high-HIV-burden African contexts

Two new studies released by Epicentre, the research arm of the international medical humanitarian organization Médecins Sans Frontières/ Doctors Without Borders (MSF) at the Conference on Retroviruses and Opportunistic Infections in Boston this week point to reductions in new HIV infections in areas where HIV treatment has been scaled up. Results also show viral suppression in one Malawian district twice as high as in the US.

Published
07 March 2014
From
MSF
Male life expectancy nine years shorter due to lower male uptake of HIV treatment in rural South Africa

Male life expectancy in rural South Africa has improved far less dramatically than women’s life expectancy since the introduction of antiretroviral therapy, due to a growing disparity in

Published
06 March 2014
By
Keith Alcorn
HIV disappears in 'Los Angeles baby,' doctors say

The girl, who was born in April and is being referred to as the "Los Angeles baby," remains on three standard HIV medications. Because of this, doctors cannot say for certain yet whether the infant is cured or whether the disease has gone into remission.

Published
06 March 2014
From
Los Angeles Times
Transmitted HIV Resistance Rate Close to 20% in Large Study of US MSM

More than 17% of antiretroviral-naive men who have sex with men (MSM) in a large US study carried antiretroviral-resistant virus, according to a nationwide analysis by the Centers for Disease Control and Prevention (CDC)]. MSM under 30 years old had close to a 19% prevalence of transmitted resistant HIV.

Published
06 March 2014
From
NATAP
Raltegravir plus boosted darunavir shown to be safe and effective for first-line ART

An NRTI-sparing initial regimen of raltegravir (Isentress) plus boosted darunavir (Prezista) worked as well as traditional antiretroviral therapy containing tenofovir/emtricitabine (the drugs in Truvada), according to

Published
06 March 2014
By
Liz Highleyman
HIV attachment inhibitor BMS-663068 shows good safety and efficacy in phase 2b study

Combination therapy using a novel HIV attachment inhibitor demonstrated good safety and effectiveness, offering the promise of a new antiretroviral class that may be particularly beneficial for

Published
06 March 2014
By
Liz Highleyman

Filter by country